EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bio-Rad Laboratories's enterprise value is $8,336 Mil.
Bio-Rad Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-655 Mil. Therefore, Bio-Rad Laboratories's EV-to-EBITDA for today is -12.73.
The historical rank and industry rank for Bio-Rad Laboratories's EV-to-EBITDA or its related term are showing as below:
BIO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -237.71 Med: 9.13 Max: 1752.58
Current: -12.73
During the past 13 years, the highest EV-to-EBITDA of Bio-Rad Laboratories was 1752.58. The lowest was -237.71. And the median was 9.13.
BIO's EV-to-EBITDA is ranked worse than 100% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 14.755
vs BIO: -12.73
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-18), Bio-Rad Laboratories's stock price is $290.86.
Bio-Rad Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.490. Therefore, Bio-Rad Laboratories's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Bio-Rad Laboratories EV-to-EBITDA Historical Data
The historical data trend for Bio-Rad Laboratories's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bio-Rad Laboratories Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-EBITDA
4.39
3.27
3.93
-2.66
-13.76
Bio-Rad Laboratories Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBITDA
-2.66
-209.34
-31.20
1,756.32
-13.76
Competitive Comparison
For the Medical Devices subindustry, Bio-Rad Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Rad Laboratories EV-to-EBITDA Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bio-Rad Laboratories's EV-to-EBITDA falls into.
Bio-Rad Laboratories EV-to-EBITDA Calculation
Bio-Rad Laboratories's EV-to-EBITDA for today is calculated as:
Bio-Rad Laboratories's current Enterprise Value is $8,336 Mil.
Bio-Rad Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-655 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bio-Rad Laboratories's PE Ratio for today is calculated as:
Bio-Rad Laboratories's share price for today is $290.86.
Bio-Rad Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.490.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Bio-Rad Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIO has been successfully added to your 